nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—acquired immunodeficiency syndrome—sarcoma	0.654	1	CtDrD
Nelfinavir—CYP2B6—Thiotepa—sarcoma	0.0423	0.149	CbGbCtD
Nelfinavir—ABCG2—Dactinomycin—sarcoma	0.0289	0.102	CbGbCtD
Nelfinavir—ABCG2—Mitoxantrone—sarcoma	0.0259	0.0911	CbGbCtD
Nelfinavir—ABCG2—Vincristine—sarcoma	0.0178	0.0627	CbGbCtD
Nelfinavir—ABCG2—Etoposide—sarcoma	0.0163	0.0574	CbGbCtD
Nelfinavir—CYP1A2—Dacarbazine—sarcoma	0.0137	0.0484	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0131	0.0463	CbGbCtD
Nelfinavir—CYP3A7—Vincristine—sarcoma	0.0131	0.0463	CbGbCtD
Nelfinavir—CYP3A4—Thiotepa—sarcoma	0.013	0.0458	CbGbCtD
Nelfinavir—ABCG2—Doxorubicin—sarcoma	0.0111	0.0392	CbGbCtD
Nelfinavir—ABCB1—Dactinomycin—sarcoma	0.0104	0.0367	CbGbCtD
Nelfinavir—CYP3A5—Vincristine—sarcoma	0.00986	0.0347	CbGbCtD
Nelfinavir—ABCB1—Mitoxantrone—sarcoma	0.00932	0.0328	CbGbCtD
Nelfinavir—CYP3A5—Etoposide—sarcoma	0.00903	0.0318	CbGbCtD
Nelfinavir—CYP2B6—Doxorubicin—sarcoma	0.00782	0.0276	CbGbCtD
Nelfinavir—CYP1A2—Etoposide—sarcoma	0.00672	0.0237	CbGbCtD
Nelfinavir—ABCB1—Vincristine—sarcoma	0.00642	0.0226	CbGbCtD
Nelfinavir—ABCB1—Etoposide—sarcoma	0.00588	0.0207	CbGbCtD
Nelfinavir—CYP3A4—Mitoxantrone—sarcoma	0.00559	0.0197	CbGbCtD
Nelfinavir—ABCB1—Doxorubicin—sarcoma	0.00401	0.0141	CbGbCtD
Nelfinavir—CYP3A4—Vincristine—sarcoma	0.00384	0.0135	CbGbCtD
Nelfinavir—CYP2D6—Doxorubicin—sarcoma	0.00378	0.0133	CbGbCtD
Nelfinavir—CYP3A4—Etoposide—sarcoma	0.00352	0.0124	CbGbCtD
Nelfinavir—CYP3A4—Doxorubicin—sarcoma	0.0024	0.00846	CbGbCtD
Nelfinavir—Feeling abnormal—Thiotepa—sarcoma	0.000123	0.00198	CcSEcCtD
Nelfinavir—Anorexia—Mitoxantrone—sarcoma	0.000122	0.00197	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.000122	0.00196	CcSEcCtD
Nelfinavir—Feeling abnormal—Dactinomycin—sarcoma	0.000122	0.00196	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Thiotepa—sarcoma	0.000122	0.00196	CcSEcCtD
Nelfinavir—Ill-defined disorder—Etoposide—sarcoma	0.000121	0.00196	CcSEcCtD
Nelfinavir—Anaemia—Etoposide—sarcoma	0.000121	0.00195	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Dactinomycin—sarcoma	0.000121	0.00195	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Vincristine—sarcoma	0.00012	0.00194	CcSEcCtD
Nelfinavir—Migraine—Epirubicin—sarcoma	0.00012	0.00193	CcSEcCtD
Nelfinavir—Affect lability—Epirubicin—sarcoma	0.00012	0.00193	CcSEcCtD
Nelfinavir—Insomnia—Vincristine—sarcoma	0.000119	0.00192	CcSEcCtD
Nelfinavir—Paraesthesia—Vincristine—sarcoma	0.000118	0.00191	CcSEcCtD
Nelfinavir—Urticaria—Thiotepa—sarcoma	0.000118	0.00191	CcSEcCtD
Nelfinavir—Malaise—Etoposide—sarcoma	0.000118	0.0019	CcSEcCtD
Nelfinavir—Dermatitis bullous—Doxorubicin—sarcoma	0.000118	0.0019	CcSEcCtD
Nelfinavir—Abdominal pain—Thiotepa—sarcoma	0.000118	0.0019	CcSEcCtD
Nelfinavir—Body temperature increased—Thiotepa—sarcoma	0.000118	0.0019	CcSEcCtD
Nelfinavir—Leukopenia—Etoposide—sarcoma	0.000117	0.00189	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000117	0.00189	CcSEcCtD
Nelfinavir—Abdominal pain—Dactinomycin—sarcoma	0.000117	0.00188	CcSEcCtD
Nelfinavir—Body temperature increased—Dactinomycin—sarcoma	0.000117	0.00188	CcSEcCtD
Nelfinavir—Hypoglycaemia—Doxorubicin—sarcoma	0.000116	0.00186	CcSEcCtD
Nelfinavir—Mood swings—Epirubicin—sarcoma	0.000115	0.00186	CcSEcCtD
Nelfinavir—Paraesthesia—Mitoxantrone—sarcoma	0.000115	0.00186	CcSEcCtD
Nelfinavir—Decreased appetite—Vincristine—sarcoma	0.000115	0.00185	CcSEcCtD
Nelfinavir—Dyspnoea—Mitoxantrone—sarcoma	0.000115	0.00185	CcSEcCtD
Nelfinavir—Somnolence—Mitoxantrone—sarcoma	0.000114	0.00184	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Vincristine—sarcoma	0.000114	0.00184	CcSEcCtD
Nelfinavir—Convulsion—Etoposide—sarcoma	0.000113	0.00183	CcSEcCtD
Nelfinavir—Dehydration—Epirubicin—sarcoma	0.000113	0.00183	CcSEcCtD
Nelfinavir—Dyspepsia—Mitoxantrone—sarcoma	0.000113	0.00182	CcSEcCtD
Nelfinavir—Pain—Vincristine—sarcoma	0.000113	0.00182	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000113	0.00182	CcSEcCtD
Nelfinavir—Liver function test abnormal—Epirubicin—sarcoma	0.000113	0.00181	CcSEcCtD
Nelfinavir—Decreased appetite—Mitoxantrone—sarcoma	0.000112	0.0018	CcSEcCtD
Nelfinavir—Abdominal pain upper—Epirubicin—sarcoma	0.000111	0.00179	CcSEcCtD
Nelfinavir—Affect lability—Doxorubicin—sarcoma	0.000111	0.00179	CcSEcCtD
Nelfinavir—Migraine—Doxorubicin—sarcoma	0.000111	0.00179	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000111	0.00178	CcSEcCtD
Nelfinavir—Discomfort—Etoposide—sarcoma	0.00011	0.00178	CcSEcCtD
Nelfinavir—Pain—Mitoxantrone—sarcoma	0.00011	0.00177	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.00011	0.00177	CcSEcCtD
Nelfinavir—Hypersensitivity—Thiotepa—sarcoma	0.00011	0.00177	CcSEcCtD
Nelfinavir—Hypersensitivity—Dactinomycin—sarcoma	0.000109	0.00175	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Vincristine—sarcoma	0.000108	0.00174	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000107	0.00173	CcSEcCtD
Nelfinavir—Muscular weakness—Epirubicin—sarcoma	0.000107	0.00173	CcSEcCtD
Nelfinavir—Mood swings—Doxorubicin—sarcoma	0.000107	0.00172	CcSEcCtD
Nelfinavir—Asthenia—Thiotepa—sarcoma	0.000107	0.00172	CcSEcCtD
Nelfinavir—Abdominal distension—Epirubicin—sarcoma	0.000106	0.00171	CcSEcCtD
Nelfinavir—Asthenia—Dactinomycin—sarcoma	0.000106	0.00171	CcSEcCtD
Nelfinavir—Feeling abnormal—Mitoxantrone—sarcoma	0.000106	0.00171	CcSEcCtD
Nelfinavir—Pruritus—Thiotepa—sarcoma	0.000105	0.0017	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000105	0.00169	CcSEcCtD
Nelfinavir—Dehydration—Doxorubicin—sarcoma	0.000105	0.00169	CcSEcCtD
Nelfinavir—Thrombocytopenia—Etoposide—sarcoma	0.000105	0.00169	CcSEcCtD
Nelfinavir—Body temperature increased—Vincristine—sarcoma	0.000104	0.00168	CcSEcCtD
Nelfinavir—Abdominal pain—Vincristine—sarcoma	0.000104	0.00168	CcSEcCtD
Nelfinavir—Liver function test abnormal—Doxorubicin—sarcoma	0.000104	0.00168	CcSEcCtD
Nelfinavir—Skin disorder—Etoposide—sarcoma	0.000104	0.00167	CcSEcCtD
Nelfinavir—Hyperhidrosis—Etoposide—sarcoma	0.000103	0.00167	CcSEcCtD
Nelfinavir—Pancreatitis—Epirubicin—sarcoma	0.000103	0.00166	CcSEcCtD
Nelfinavir—Abdominal pain upper—Doxorubicin—sarcoma	0.000103	0.00166	CcSEcCtD
Nelfinavir—Urticaria—Mitoxantrone—sarcoma	0.000102	0.00165	CcSEcCtD
Nelfinavir—Anorexia—Etoposide—sarcoma	0.000102	0.00164	CcSEcCtD
Nelfinavir—Diarrhoea—Thiotepa—sarcoma	0.000102	0.00164	CcSEcCtD
Nelfinavir—Abdominal pain—Mitoxantrone—sarcoma	0.000102	0.00164	CcSEcCtD
Nelfinavir—Body temperature increased—Mitoxantrone—sarcoma	0.000102	0.00164	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000102	0.00164	CcSEcCtD
Nelfinavir—Diarrhoea—Dactinomycin—sarcoma	0.000101	0.00163	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Doxorubicin—sarcoma	9.95e-05	0.0016	CcSEcCtD
Nelfinavir—Muscular weakness—Doxorubicin—sarcoma	9.95e-05	0.0016	CcSEcCtD
Nelfinavir—Neutropenia—Epirubicin—sarcoma	9.85e-05	0.00159	CcSEcCtD
Nelfinavir—Dizziness—Thiotepa—sarcoma	9.84e-05	0.00159	CcSEcCtD
Nelfinavir—Abdominal distension—Doxorubicin—sarcoma	9.81e-05	0.00158	CcSEcCtD
Nelfinavir—Hypersensitivity—Vincristine—sarcoma	9.72e-05	0.00157	CcSEcCtD
Nelfinavir—Paraesthesia—Etoposide—sarcoma	9.6e-05	0.00155	CcSEcCtD
Nelfinavir—Pancreatitis—Doxorubicin—sarcoma	9.56e-05	0.00154	CcSEcCtD
Nelfinavir—Dyspnoea—Etoposide—sarcoma	9.53e-05	0.00154	CcSEcCtD
Nelfinavir—Hyperglycaemia—Epirubicin—sarcoma	9.5e-05	0.00153	CcSEcCtD
Nelfinavir—Somnolence—Etoposide—sarcoma	9.5e-05	0.00153	CcSEcCtD
Nelfinavir—Hypersensitivity—Mitoxantrone—sarcoma	9.47e-05	0.00153	CcSEcCtD
Nelfinavir—Asthenia—Vincristine—sarcoma	9.46e-05	0.00153	CcSEcCtD
Nelfinavir—Vomiting—Thiotepa—sarcoma	9.46e-05	0.00152	CcSEcCtD
Nelfinavir—Pneumonia—Epirubicin—sarcoma	9.45e-05	0.00152	CcSEcCtD
Nelfinavir—Vomiting—Dactinomycin—sarcoma	9.39e-05	0.00151	CcSEcCtD
Nelfinavir—Rash—Thiotepa—sarcoma	9.38e-05	0.00151	CcSEcCtD
Nelfinavir—Dermatitis—Thiotepa—sarcoma	9.37e-05	0.00151	CcSEcCtD
Nelfinavir—Headache—Thiotepa—sarcoma	9.32e-05	0.0015	CcSEcCtD
Nelfinavir—Rash—Dactinomycin—sarcoma	9.31e-05	0.0015	CcSEcCtD
Nelfinavir—Decreased appetite—Etoposide—sarcoma	9.29e-05	0.0015	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Etoposide—sarcoma	9.23e-05	0.00149	CcSEcCtD
Nelfinavir—Asthenia—Mitoxantrone—sarcoma	9.22e-05	0.00149	CcSEcCtD
Nelfinavir—Stomatitis—Epirubicin—sarcoma	9.15e-05	0.00148	CcSEcCtD
Nelfinavir—Jaundice—Epirubicin—sarcoma	9.15e-05	0.00148	CcSEcCtD
Nelfinavir—Pain—Etoposide—sarcoma	9.14e-05	0.00147	CcSEcCtD
Nelfinavir—Neutropenia—Doxorubicin—sarcoma	9.11e-05	0.00147	CcSEcCtD
Nelfinavir—Diarrhoea—Vincristine—sarcoma	9.03e-05	0.00145	CcSEcCtD
Nelfinavir—Sweating—Epirubicin—sarcoma	9e-05	0.00145	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Epirubicin—sarcoma	8.88e-05	0.00143	CcSEcCtD
Nelfinavir—Epistaxis—Epirubicin—sarcoma	8.86e-05	0.00143	CcSEcCtD
Nelfinavir—Nausea—Thiotepa—sarcoma	8.84e-05	0.00142	CcSEcCtD
Nelfinavir—Sinusitis—Epirubicin—sarcoma	8.81e-05	0.00142	CcSEcCtD
Nelfinavir—Feeling abnormal—Etoposide—sarcoma	8.81e-05	0.00142	CcSEcCtD
Nelfinavir—Hyperglycaemia—Doxorubicin—sarcoma	8.79e-05	0.00142	CcSEcCtD
Nelfinavir—Diarrhoea—Mitoxantrone—sarcoma	8.79e-05	0.00142	CcSEcCtD
Nelfinavir—Nausea—Dactinomycin—sarcoma	8.77e-05	0.00141	CcSEcCtD
Nelfinavir—Pneumonia—Doxorubicin—sarcoma	8.74e-05	0.00141	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Etoposide—sarcoma	8.74e-05	0.00141	CcSEcCtD
Nelfinavir—Dizziness—Vincristine—sarcoma	8.72e-05	0.00141	CcSEcCtD
Nelfinavir—Urticaria—Etoposide—sarcoma	8.49e-05	0.00137	CcSEcCtD
Nelfinavir—Haemoglobin—Epirubicin—sarcoma	8.47e-05	0.00137	CcSEcCtD
Nelfinavir—Jaundice—Doxorubicin—sarcoma	8.47e-05	0.00137	CcSEcCtD
Nelfinavir—Stomatitis—Doxorubicin—sarcoma	8.47e-05	0.00137	CcSEcCtD
Nelfinavir—Rhinitis—Epirubicin—sarcoma	8.45e-05	0.00136	CcSEcCtD
Nelfinavir—Body temperature increased—Etoposide—sarcoma	8.45e-05	0.00136	CcSEcCtD
Nelfinavir—Abdominal pain—Etoposide—sarcoma	8.45e-05	0.00136	CcSEcCtD
Nelfinavir—Haemorrhage—Epirubicin—sarcoma	8.43e-05	0.00136	CcSEcCtD
Nelfinavir—Hepatitis—Epirubicin—sarcoma	8.43e-05	0.00136	CcSEcCtD
Nelfinavir—Vomiting—Vincristine—sarcoma	8.39e-05	0.00135	CcSEcCtD
Nelfinavir—Pharyngitis—Epirubicin—sarcoma	8.37e-05	0.00135	CcSEcCtD
Nelfinavir—Sweating—Doxorubicin—sarcoma	8.33e-05	0.00134	CcSEcCtD
Nelfinavir—Rash—Vincristine—sarcoma	8.32e-05	0.00134	CcSEcCtD
Nelfinavir—Dermatitis—Vincristine—sarcoma	8.31e-05	0.00134	CcSEcCtD
Nelfinavir—Connective tissue disorder—Epirubicin—sarcoma	8.29e-05	0.00134	CcSEcCtD
Nelfinavir—Headache—Vincristine—sarcoma	8.26e-05	0.00133	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Doxorubicin—sarcoma	8.22e-05	0.00132	CcSEcCtD
Nelfinavir—Epistaxis—Doxorubicin—sarcoma	8.2e-05	0.00132	CcSEcCtD
Nelfinavir—Vomiting—Mitoxantrone—sarcoma	8.17e-05	0.00132	CcSEcCtD
Nelfinavir—Sinusitis—Doxorubicin—sarcoma	8.15e-05	0.00131	CcSEcCtD
Nelfinavir—Rash—Mitoxantrone—sarcoma	8.1e-05	0.00131	CcSEcCtD
Nelfinavir—Dermatitis—Mitoxantrone—sarcoma	8.09e-05	0.0013	CcSEcCtD
Nelfinavir—Headache—Mitoxantrone—sarcoma	8.05e-05	0.0013	CcSEcCtD
Nelfinavir—Erythema multiforme—Epirubicin—sarcoma	7.97e-05	0.00129	CcSEcCtD
Nelfinavir—Eye disorder—Epirubicin—sarcoma	7.88e-05	0.00127	CcSEcCtD
Nelfinavir—Hypersensitivity—Etoposide—sarcoma	7.87e-05	0.00127	CcSEcCtD
Nelfinavir—Haemoglobin—Doxorubicin—sarcoma	7.84e-05	0.00126	CcSEcCtD
Nelfinavir—Nausea—Vincristine—sarcoma	7.84e-05	0.00126	CcSEcCtD
Nelfinavir—Rhinitis—Doxorubicin—sarcoma	7.82e-05	0.00126	CcSEcCtD
Nelfinavir—Hepatitis—Doxorubicin—sarcoma	7.8e-05	0.00126	CcSEcCtD
Nelfinavir—Haemorrhage—Doxorubicin—sarcoma	7.8e-05	0.00126	CcSEcCtD
Nelfinavir—Pharyngitis—Doxorubicin—sarcoma	7.74e-05	0.00125	CcSEcCtD
Nelfinavir—Asthenia—Etoposide—sarcoma	7.67e-05	0.00124	CcSEcCtD
Nelfinavir—Connective tissue disorder—Doxorubicin—sarcoma	7.67e-05	0.00124	CcSEcCtD
Nelfinavir—Angiopathy—Epirubicin—sarcoma	7.65e-05	0.00123	CcSEcCtD
Nelfinavir—Nausea—Mitoxantrone—sarcoma	7.63e-05	0.00123	CcSEcCtD
Nelfinavir—Immune system disorder—Epirubicin—sarcoma	7.62e-05	0.00123	CcSEcCtD
Nelfinavir—Pruritus—Etoposide—sarcoma	7.56e-05	0.00122	CcSEcCtD
Nelfinavir—Erythema multiforme—Doxorubicin—sarcoma	7.38e-05	0.00119	CcSEcCtD
Nelfinavir—Malnutrition—Epirubicin—sarcoma	7.34e-05	0.00118	CcSEcCtD
Nelfinavir—Erythema—Epirubicin—sarcoma	7.34e-05	0.00118	CcSEcCtD
Nelfinavir—Diarrhoea—Etoposide—sarcoma	7.31e-05	0.00118	CcSEcCtD
Nelfinavir—Eye disorder—Doxorubicin—sarcoma	7.29e-05	0.00118	CcSEcCtD
Nelfinavir—Flatulence—Epirubicin—sarcoma	7.23e-05	0.00117	CcSEcCtD
Nelfinavir—Back pain—Epirubicin—sarcoma	7.1e-05	0.00114	CcSEcCtD
Nelfinavir—Angiopathy—Doxorubicin—sarcoma	7.08e-05	0.00114	CcSEcCtD
Nelfinavir—Dizziness—Etoposide—sarcoma	7.07e-05	0.00114	CcSEcCtD
Nelfinavir—Muscle spasms—Epirubicin—sarcoma	7.06e-05	0.00114	CcSEcCtD
Nelfinavir—Immune system disorder—Doxorubicin—sarcoma	7.05e-05	0.00114	CcSEcCtD
Nelfinavir—Ill-defined disorder—Epirubicin—sarcoma	6.81e-05	0.0011	CcSEcCtD
Nelfinavir—Vomiting—Etoposide—sarcoma	6.79e-05	0.0011	CcSEcCtD
Nelfinavir—Malnutrition—Doxorubicin—sarcoma	6.79e-05	0.00109	CcSEcCtD
Nelfinavir—Erythema—Doxorubicin—sarcoma	6.79e-05	0.00109	CcSEcCtD
Nelfinavir—Anaemia—Epirubicin—sarcoma	6.78e-05	0.00109	CcSEcCtD
Nelfinavir—Agitation—Epirubicin—sarcoma	6.74e-05	0.00109	CcSEcCtD
Nelfinavir—Rash—Etoposide—sarcoma	6.74e-05	0.00109	CcSEcCtD
Nelfinavir—Dermatitis—Etoposide—sarcoma	6.73e-05	0.00109	CcSEcCtD
Nelfinavir—Headache—Etoposide—sarcoma	6.69e-05	0.00108	CcSEcCtD
Nelfinavir—Flatulence—Doxorubicin—sarcoma	6.69e-05	0.00108	CcSEcCtD
Nelfinavir—Malaise—Epirubicin—sarcoma	6.62e-05	0.00107	CcSEcCtD
Nelfinavir—Leukopenia—Epirubicin—sarcoma	6.57e-05	0.00106	CcSEcCtD
Nelfinavir—Back pain—Doxorubicin—sarcoma	6.57e-05	0.00106	CcSEcCtD
Nelfinavir—Muscle spasms—Doxorubicin—sarcoma	6.53e-05	0.00105	CcSEcCtD
Nelfinavir—Convulsion—Epirubicin—sarcoma	6.36e-05	0.00103	CcSEcCtD
Nelfinavir—Nausea—Etoposide—sarcoma	6.35e-05	0.00102	CcSEcCtD
Nelfinavir—Ill-defined disorder—Doxorubicin—sarcoma	6.3e-05	0.00102	CcSEcCtD
Nelfinavir—Anaemia—Doxorubicin—sarcoma	6.28e-05	0.00101	CcSEcCtD
Nelfinavir—Myalgia—Epirubicin—sarcoma	6.25e-05	0.00101	CcSEcCtD
Nelfinavir—Arthralgia—Epirubicin—sarcoma	6.25e-05	0.00101	CcSEcCtD
Nelfinavir—Agitation—Doxorubicin—sarcoma	6.24e-05	0.00101	CcSEcCtD
Nelfinavir—Anxiety—Epirubicin—sarcoma	6.23e-05	0.001	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	6.21e-05	0.001	CcSEcCtD
Nelfinavir—Discomfort—Epirubicin—sarcoma	6.17e-05	0.000995	CcSEcCtD
Nelfinavir—Malaise—Doxorubicin—sarcoma	6.12e-05	0.000987	CcSEcCtD
Nelfinavir—Leukopenia—Doxorubicin—sarcoma	6.08e-05	0.00098	CcSEcCtD
Nelfinavir—Oedema—Epirubicin—sarcoma	5.99e-05	0.000966	CcSEcCtD
Nelfinavir—Convulsion—Doxorubicin—sarcoma	5.88e-05	0.000948	CcSEcCtD
Nelfinavir—Thrombocytopenia—Epirubicin—sarcoma	5.86e-05	0.000945	CcSEcCtD
Nelfinavir—Skin disorder—Epirubicin—sarcoma	5.82e-05	0.000938	CcSEcCtD
Nelfinavir—Hyperhidrosis—Epirubicin—sarcoma	5.79e-05	0.000933	CcSEcCtD
Nelfinavir—Arthralgia—Doxorubicin—sarcoma	5.78e-05	0.000932	CcSEcCtD
Nelfinavir—Myalgia—Doxorubicin—sarcoma	5.78e-05	0.000932	CcSEcCtD
Nelfinavir—Anxiety—Doxorubicin—sarcoma	5.76e-05	0.000929	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	5.74e-05	0.000926	CcSEcCtD
Nelfinavir—Discomfort—Doxorubicin—sarcoma	5.71e-05	0.000921	CcSEcCtD
Nelfinavir—Anorexia—Epirubicin—sarcoma	5.71e-05	0.00092	CcSEcCtD
Nelfinavir—Oedema—Doxorubicin—sarcoma	5.54e-05	0.000893	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Epirubicin—sarcoma	5.46e-05	0.00088	CcSEcCtD
Nelfinavir—Thrombocytopenia—Doxorubicin—sarcoma	5.43e-05	0.000875	CcSEcCtD
Nelfinavir—Insomnia—Epirubicin—sarcoma	5.42e-05	0.000873	CcSEcCtD
Nelfinavir—Skin disorder—Doxorubicin—sarcoma	5.38e-05	0.000868	CcSEcCtD
Nelfinavir—Paraesthesia—Epirubicin—sarcoma	5.38e-05	0.000867	CcSEcCtD
Nelfinavir—Hyperhidrosis—Doxorubicin—sarcoma	5.36e-05	0.000864	CcSEcCtD
Nelfinavir—Dyspnoea—Epirubicin—sarcoma	5.34e-05	0.000861	CcSEcCtD
Nelfinavir—Somnolence—Epirubicin—sarcoma	5.33e-05	0.000858	CcSEcCtD
Nelfinavir—Anorexia—Doxorubicin—sarcoma	5.28e-05	0.000852	CcSEcCtD
Nelfinavir—Dyspepsia—Epirubicin—sarcoma	5.27e-05	0.00085	CcSEcCtD
Nelfinavir—Decreased appetite—Epirubicin—sarcoma	5.21e-05	0.000839	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Epirubicin—sarcoma	5.17e-05	0.000834	CcSEcCtD
Nelfinavir—Pain—Epirubicin—sarcoma	5.12e-05	0.000826	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Doxorubicin—sarcoma	5.05e-05	0.000814	CcSEcCtD
Nelfinavir—Insomnia—Doxorubicin—sarcoma	5.01e-05	0.000808	CcSEcCtD
Nelfinavir—Paraesthesia—Doxorubicin—sarcoma	4.98e-05	0.000802	CcSEcCtD
Nelfinavir—Dyspnoea—Doxorubicin—sarcoma	4.94e-05	0.000797	CcSEcCtD
Nelfinavir—Feeling abnormal—Epirubicin—sarcoma	4.94e-05	0.000796	CcSEcCtD
Nelfinavir—Somnolence—Doxorubicin—sarcoma	4.93e-05	0.000794	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Epirubicin—sarcoma	4.9e-05	0.00079	CcSEcCtD
Nelfinavir—Dyspepsia—Doxorubicin—sarcoma	4.88e-05	0.000786	CcSEcCtD
Nelfinavir—Decreased appetite—Doxorubicin—sarcoma	4.82e-05	0.000777	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Doxorubicin—sarcoma	4.79e-05	0.000771	CcSEcCtD
Nelfinavir—Urticaria—Epirubicin—sarcoma	4.76e-05	0.000767	CcSEcCtD
Nelfinavir—Pain—Doxorubicin—sarcoma	4.74e-05	0.000764	CcSEcCtD
Nelfinavir—Body temperature increased—Epirubicin—sarcoma	4.74e-05	0.000763	CcSEcCtD
Nelfinavir—Abdominal pain—Epirubicin—sarcoma	4.74e-05	0.000763	CcSEcCtD
Nelfinavir—Feeling abnormal—Doxorubicin—sarcoma	4.57e-05	0.000736	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Doxorubicin—sarcoma	4.53e-05	0.000731	CcSEcCtD
Nelfinavir—Hypersensitivity—Epirubicin—sarcoma	4.41e-05	0.000711	CcSEcCtD
Nelfinavir—Urticaria—Doxorubicin—sarcoma	4.4e-05	0.00071	CcSEcCtD
Nelfinavir—Abdominal pain—Doxorubicin—sarcoma	4.38e-05	0.000706	CcSEcCtD
Nelfinavir—Body temperature increased—Doxorubicin—sarcoma	4.38e-05	0.000706	CcSEcCtD
Nelfinavir—Asthenia—Epirubicin—sarcoma	4.3e-05	0.000693	CcSEcCtD
Nelfinavir—Pruritus—Epirubicin—sarcoma	4.24e-05	0.000683	CcSEcCtD
Nelfinavir—Diarrhoea—Epirubicin—sarcoma	4.1e-05	0.000661	CcSEcCtD
Nelfinavir—Hypersensitivity—Doxorubicin—sarcoma	4.08e-05	0.000658	CcSEcCtD
Nelfinavir—Asthenia—Doxorubicin—sarcoma	3.98e-05	0.000641	CcSEcCtD
Nelfinavir—Dizziness—Epirubicin—sarcoma	3.96e-05	0.000639	CcSEcCtD
Nelfinavir—Pruritus—Doxorubicin—sarcoma	3.92e-05	0.000632	CcSEcCtD
Nelfinavir—Vomiting—Epirubicin—sarcoma	3.81e-05	0.000614	CcSEcCtD
Nelfinavir—Diarrhoea—Doxorubicin—sarcoma	3.79e-05	0.000611	CcSEcCtD
Nelfinavir—Rash—Epirubicin—sarcoma	3.78e-05	0.000609	CcSEcCtD
Nelfinavir—Dermatitis—Epirubicin—sarcoma	3.77e-05	0.000608	CcSEcCtD
Nelfinavir—Headache—Epirubicin—sarcoma	3.75e-05	0.000605	CcSEcCtD
Nelfinavir—Dizziness—Doxorubicin—sarcoma	3.67e-05	0.000591	CcSEcCtD
Nelfinavir—Nausea—Epirubicin—sarcoma	3.56e-05	0.000574	CcSEcCtD
Nelfinavir—Vomiting—Doxorubicin—sarcoma	3.52e-05	0.000568	CcSEcCtD
Nelfinavir—Rash—Doxorubicin—sarcoma	3.49e-05	0.000563	CcSEcCtD
Nelfinavir—Dermatitis—Doxorubicin—sarcoma	3.49e-05	0.000563	CcSEcCtD
Nelfinavir—Headache—Doxorubicin—sarcoma	3.47e-05	0.00056	CcSEcCtD
Nelfinavir—Nausea—Doxorubicin—sarcoma	3.29e-05	0.000531	CcSEcCtD
